相关实验视频

Updated: Jan 13, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

针对瘤细胞的基于RNA的分子疗法的最新进展

Navneet Sharma¹, Akash Bhati¹, Kamal Shah²

¹University Institute of Pharma Sciences (UIPS), Chandigarh University NH-05, Chandigarh, Ludhiana Highway, Mohali, Punjab, 140413, India.

Current gene therapy

|January 9, 2026

概括

基于RNA的疗法通过利用基因变异提供有针对性的癌症治疗. 研究正在推进RNA传递系统,纳米颗粒和人工智能,以提高瘤学的疗效和减少副作用.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物技术是生物技术.

背景情况:

传统上,抗癌药物开发的目标是现有的瘤细胞遗传改变.
功能丧失的基因选识别了对瘤生长,细胞毒性和亡至关重要的基因.
在癌症诊断和治疗中RNA的新兴作用是医学研究的一个重要领域.

研究的目的:

审查基于RNA的癌症治疗疗法.
讨论作用机制,临床应用和RNA输送系统的进展.
探索纳米粒子和人工智能在瘤向中的整合.

主要方法:

关于基于RNA的治疗方法的当前研究的总结.
分析各种RNA类型,包括小干扰RNA (siRNA) 和微RNA (miRNA).
审查RNA输送系统,如外体和RNA跟踪和稳定性的进展.

主要成果:

许多mRNA和寡核酸药物 (ASOs,siRNAs,aptamers,miRNAs) 正在临床开发中.
一些基于RNA的疗法已经获得临床批准.
RNA疗法在癌症治疗中表现出高的特异性和适应性.

结论:

基于RNA的疗法对癌症治疗有很大的前景.
持续的研究对于优化输送方法和尽量减少副作用至关重要.
探索新的RNA标对于将这些疗法推向广泛的临床实践至关重要.

关键词:

这是一个RNARNARNARNARNA.在RNAi疗法中使用RNAi疗法.抗癌药物是一种抗癌药物.亡 (apoptosis) 是一种死亡的过程.纳米颗粒是一种纳米粒子.这就是什么? saRNARNA.

更多相关视频

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...